Organization profile

Organisation profile

The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.

Fingerprint Dive into the research topics where RCCTM - Glioblastoma Brain Tumor is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects

    循環性miR-19b和miR-93做為早期診斷男性骨質疏鬆症之有效生物標誌的轉譯醫學研究(1/3)

    Chen, R.

    8/1/187/1/19

    Project: A - Government Institutionb - Ministry of Science and Technology

    研發血液循環性和骨頭微型核醣核酸以做為診斷或治療男性骨質疏鬆症和其所誘發骨折的生物標誌(3/3)

    Chen, R.

    8/1/177/31/18

    Project: A - Government Institutionb - Ministry of Science and Technology

    基質金屬蛋白酶-13在緩激肽調控血腦障壁通透性作用中所扮演的角色研究

    Chen, R.

    3/1/172/28/18

    Project: C - Project of Alliancer - Shin Kong Wu Ho-Su Memorial Hospital

    Research Output

    • 437 Citations
    • 12 h-Index
    • 29 Article
    • 2 Review article
    Open Access
  • Emerging role of vitamins d and k in modulating uremic vascular calcification: The aspect of passive calcification

    Hs, Y. C., Lu, C. L., Zheng, C. M., Chen, R. M., Lin, Y. F., Liu, W. C., Yen, T. H., Chen, R. & Lu, K. C., Jan 1 2019, In : Nutrients. 11, 1

    Research output: Contribution to journalReview article

  • 3 Citations (Scopus)
  • 2 Citations (Scopus)